China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for the ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ ...

Finding the right primer for dry skin is a challenge for us all – yes, including us beauty journos (hey 👋). If you're working with a flakey complexion, you'll know how annoying it is when ...

This domination is due to the repeated requirement for reagents like DNA polymerases, primers ... read whole-genome sequencing (WGS), enhancing diagnostic accuracy for individuals with various genetic ...

First Quantum Minerals (TSX: FM) has cut its copper guidance by 3.5% at the midpoint, citing Zambian mine sequencing, while politics has kept Cobre Panama idle. The Toronto-headquartered company ...

Following the Jan. 13 announcement, Illumina shares jumped 5.5% to close at $144.22 on Monday. The company has democratized sequencing over the past 20 years, and with the progress in AI and ...